Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study (Q34520174)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

object named as

Bjørn Naume

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Elin Faye Borgen

2

object named as

Elin Borgen

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jahn M. Nesland

11

object named as

Jahn Martin Nesland

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Marit Synnestvedt

1

object named as

Marit Synnestvedt

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

3

object named as

Erik Wist

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

4

object named as

Gro Wiedswang

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Cecilie Schirmer

10

object named as

Cecilie Schirmer

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

object named as

Kjetil Weyde

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Johann Christian Kerstens

7

object named as

Christian Kersten

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ingvil Mjaaland

8

object named as

Ingvil Mjaaland

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

9

object named as

Lise Vindi

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Terje Risberg

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

22 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

616

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

HER2-positive DTCs/CTCs in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Circulating tumor cells and circulating tumor DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

High-resolution array comparative genomic hybridization of single micrometastatic tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Primary systemic chemotherapy of invasive lobular carcinoma of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Dissecting the metastatic cascade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576235

7 July 2018

Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Taxane therapy for early stage breast cancer

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Adjuvant docetaxel for node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study

1 reference

https://api.crossref.org/works/10.1186/1471-2407-12-616

21 January 2018

Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential pathological application of immunocytochemical methods to the detection of micrometastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel Immunofluorescence Protocol for Multimarker Assessment of Putative Disseminating Breast Cancer Stem Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23259667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-12-616

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34520174&oldid=2196734085"